Atrophic vulvovaginitis: new trends in pharmacotherapy
The article presents the current data on the etiopathogenesis of atrophic vulvovaginitis, diagnostic criteria, clinical manifestations and modern drugs used to treat the pathological condition.
Saved in:
Main Authors: | V N Prilepskaya (Author), A V Ledina (Author) |
---|---|
Format: | Book |
Published: |
IP Berlin A.V.,
2013-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Estriol (local and systemic forms) in the treatment of atrophic vulvovaginitis
by: V N Prilepskaya, et al.
Published: (2015) -
Glycyrrhizic acid in the chronic vulvovaginitis and cervicitis treatment
by: A V Ledina, et al.
Published: (2013) -
Vulvovaginitis and vaginosis treatment: clinical and laboratory efficiency
by: V N Prilepskaya, et al.
Published: (2013) -
Vulvovaginitis. Treatment with the use of complex preparations for topical application
by: V N Prilepskaya, et al.
Published: (2015) -
Editorial: New Trends and Approaches in Perioperative Pharmacotherapy: An Update
by: S. Soghomonyan, et al.
Published: (2021)